EULAR 2018 – ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY
RAI AmsterdamAmsterdam, NETHERLANDS Visit the Venue to read more
The next EULAR Annual European Congress of Rheumatology will take place from 13–16 June 2018 in Amsterdam, Netherlands. The annual EULAR Congress continues to be a major event in the calendar of world rheumatology and Amsterdam 2018 will again provide an unique event for the exchange of scientific and clinical information. It will be a platform to facilitate interactions between patients, medical doctors, scientists, health professionals and professionals representing the pharmaceutical industry, both from within Europe and from around the world. In addition, we will also see further results from our initiatives, the EULAR School of Rheumatology, the “Don’t Delay, Connect Today” campaign and the launch of the EULAR Strategy 2018-2023.
EULAR Congresses have, rightly so, received tremendous interest in terms of participation and quality of contributions. This also reflects the availability of increased information on the impact, burden and cost of rheumatic and musculoskeletal diseases for the individual and society, and a significantly improved ability to diagnose and treat them (early). The incorporation of health professional and patient organisations within EULAR has been a unique stimulus for these advances. This intensive cooperation facilitates, for instance, the implementation of recommendations for management/standards of care of musculoskeletal disorders in daily practice – of which we have seen prime examples at our EULAR Congresses.
The EULAR Congress 2018 in Amsterdam will offer a wide range of topics including clinical innovations, clinical translational and basic science. Furthermore, there will be meetings organised by People with Arthritis and Rheumatism in Europe (PARE), Health Professionals in Rheumatology (HPR) and by the health care industry. The WIN/HOT track for the busy clinician who wants an update on What is New and How to Treat the major rheumatic diseases has become a much praised highlight of the EULAR Congress. Another crucial activity of the congress are the poster presentations and poster tours with their highly interactive exchanges among participants. The Amsterdam event will further strengthen the reputation of the EULAR Congress as a highly innovative and informative venue for clinical and translational researchers - not only within the different facets of our discipline (including inflammation, pain, bone, mechanical and in ammatory disorders), but also learning from other relevant disciplines. The Amsterdam meeting will further promote the reputation of the EULAR Congress as the most innovative and informative venue for clinical research for the practising physician. The EULAR EMEUNET organisation of young rheumatologists will continue to attract young colleagues to the meeting and will disseminate the message that rheumatology is one of the most attractive and successful disciplines of medicine.
We are very happy to visit the City of Amsterdam again. In 2006, we were impressed by the magnificent ambiance of canals and canalside houses, galleries, astonishing museums (think Rembrandt, Vermeer, Rubens, Steen and Van Gogh), the Anne Frank House, theatres, music and culinary pleasures. In June even the Dutch weather might be very pleasant. Thus, Amsterdam will provide an excellent background for scientific and clinical exchanges, international collaborations and renewal of friendships. We will take great pleasure in welcoming medical doctors, patients, health professionals and representatives of the pharmaceutical industry to EULAR 2018, and hope that their stay in Amsterdam will be informative, educational and, last but not least, enjoyable.
Johannes W. J. Bijlsma
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
MCI has reserved a large number of hotel rooms in various hotels in different price categories. The majority of hotels are located in the city centre but also in the surroundings of the congress venue, RAI. Please note that Amsterdam attracts many tourists. Hotel reservations will be made on a first come, first-served basis.
Please book before 25 April 2018 in order to guarantee your booking.
Group bookings: For bookings of up to 9 rooms, please use the small groups' button on the registration page. For bookings of more than 9 rooms, please contact MCI Suisse SA for an offer matching your needs: firstname.lastname@example.org.
Please address all enquiries, requests for additional information and changes or cancellations of room reservations directly to MCI.
c/o MCI SUISSE SA
9, Rue du Pré-Bouvier
CH 1242 Satigny
Tel +41 22 33 99 590
Fax +41 22 33 99 631
Abstracts can only be submitted online via the online abstract submission system.
Abstracts sent by post or email will not be accepted. No exceptions will be made.
The internet abstract submission system works best with Internet Explorer 8.0 or higher and Mozilla Firefox 5.0 or higher and Chrome 16 or higher.
Abstract submission must be in one of the three different categories:
a. Medical or Research Professional / Clinician
b. Health Professional in Rheumatology / Practice and Research
c. PARE Member / Patient
The categories are subdivided into topics (Abstract topics).
The correct category and topic must be selected to ensure correct scoring.
The content of the abstract must be topic related.
Splitting of data originating from the same study across several abstracts and/or
topics is not permitted and will lead to rejection of the abstracts.
Please read all instructions carefully before preparing your abstract.
For standardisation, the acceptable length of the abstract is not more than 3600 characters and 55 lines, authors’ details and headers included. This also includes non-visible characters such as spaces as well as punctuation.
The abstract should be structured into the following sections:
a. A title which clearly indicates the nature of the investigation
Up to two tables can be included in the results section with the following criteria:
• Maximum number of columns: 12
• Maximum number of rows: 20
• If a second table is added the number of columns and rows decreases by the
number of columns/rows used in the first table
One graph/image can be included with the following criteria :
Image widthmin. 50 pixelsmax. 750 pixels
Image heightmin. 50 pixelsmax. 750 pixels
Image qualitymin. 96 dpimax. 300 dpi
Image file sizemin. 40 KBmax. 1000 KB (1MB)
Allowed file typegif, jpg
Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline (31 January 2018, 23:59 CET).
Therefore, the submitter will be required to create a user account.
Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the congress. Abstracts in “Final submission” status can be re-edited and modified until the submission deadline (31 January 2018, 23:59 CET).
An abstract can only be submitted if the “Rules and Regulations including the
EULAR Embargo Rules” on the online abstract form are read and accepted.
Conflict of interest: It is the intent of EULAR to provide highquality sessions focused on educational content that is free from commercial influence or bias. Thus the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstracts submission.
The presenting author can be any of the listed authors, preferably without affiliations
The inclusion of trade names/brand names is not allowed in the abstract. The mentioning of agents/molecules must follow the scientific standard for publications.
Abstracts accepted for the congress are subject to the “EULAR Embargo Rules” and the “Transfer of copyright” as published in the right column on this page. With the submission of an abstract the authors agree to the embargo rules and the transfer of copyright.
The corresponding author has the right to grant, and does grant on behalf of all authors an exclusive licence on a worldwide basis to the BMJ Publishing Group Ltd and EULAR to publish the abstract (if accepted) in any media and to exploit all subsidiary rights.
Only abstracts that contain original data can be submitted.
Abstracts should not be submitted if the following applies:
a. The abstract contains data that has been published or accepted for publication in
a print or online journal
b. The abstract contains data that was presented at a scientific meeting more than
12 months prior to EULAR 2018
Abstracts containing data that has been presented or will be presented at a different scientific meeting during a 12 months period prior to EULAR 2018 can be submitted. This fact must be indicated on the submission form.
Abstracts having been submitted for publication or to a scientific meeting, but are pending acceptance, can be submitted without restrictions. However, once the abstract has been accepted by EULAR it is automatically subject to the EULAR embargo rules.
The reviewers will judge the abstracts according to the scientific or clinical value,
relevance to EULAR, suitability of methods to aims, conclusions confirmed by objective results, objectivity of statements, description of methods used, ethics, originality of work, standard of English and overall impression.
Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done.
Abstract acceptance will be in one of three categories: oral presentation, poster presentation, publication only.
Abstract submission deadline 2018-02-28
For further information regarding the partnership & investment opportunities,
c/o MCI SUISSE SA
9, Rue du Pré-Bouvier
Tel +41 22 33 99 590
Fax +41 22 33 99 601
During the congress EULAR will present an attractive exhibition to all delegates. The abstract poster presentation area is embedded in the exhibition. Coffee and other refreshments will be available in the exhibition and poster area. The exhibition will open officially on Wednesday 13 June 2018.
Exhibition hours will be as follows
Wednesday13 June 201812:00–18:00
Thursday14 June 201808:00–17:15
Friday15 June 201808:00–17:15
Saturday16 June 201808:45–14:00
Organising Secretariat EULAR 2018 , MCI Group